Hotaling Investment Management, LLC Charles River Laboratories International, Inc. Transaction History

Hotaling Investment Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	SELL	$255.51 - $362.11 $237,368 - $336,400	-929 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$351.38 - $448.68 $3,162 - $4,038	9 Added 0.98%	929 $350,000
Q3 2021 Oct 21, 2021	BUY	$372.64 - $458.3 $18,632 - $22,915	50 Added 5.75%	920 $380,000
Q1 2021 May 11, 2021	SELL	$249.67 - $299.48 $12,982 - $15,572	-52 Reduced 5.64%	870 $252,000
Q4 2020 Jan 22, 2021	SELL	$222.0 - $252.62 $3,108 - $3,536	-14 Reduced 1.5%	922 $230,000
Q3 2020 Nov 04, 2020	BUY	$175.56 - $226.45 $164,324 - $211,957	936 New	936 $212,000
Q2 2020 Jul 31, 2020	SELL	$118.84 - $189.72 $198,462 - $316,832	-1,670 Closed	0 $0
Q1 2020 Apr 08, 2020	SELL	$98.9 - $178.34 $10,582 - $19,082	-107 Reduced 6.02%	1,670 $211,000
Q4 2019 Jan 28, 2020	BUY	$126.05 - $152.76 $1,890 - $2,291	15 Added 0.85%	1,777 $271,000
Q3 2019 Oct 28, 2019	BUY	$125.07 - $143.67 $1,876 - $2,155	15 Added 0.86%	1,762 $233,000
Q2 2019 Aug 08, 2019	BUY	$123.4 - $148.55 $2,468 - $2,971	20 Added 1.16%	1,747 $248,000
Q1 2019 May 01, 2019	BUY	$104.82 - $146.73 $181,024 - $253,402	1,727 New	1,727 $251,000

693

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.55B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Hotaling Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hotaling Investment Management, LLC with notifications on news.